Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
The superior Agilent 6495 Triple Quadrupole LC/MS (LC/TQ) System is ideal for demanding and challenging targeted analysis applications requiring the highest analytical sensitivity
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Nous-209 has been developed using the Nouscom's viral vector platform
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Subscribe To Our Newsletter & Stay Updated
